May 11, 2026 9:28 pm

Mike Rogers Misrepresents Opioid Record in Michigan Senate Bid

Mike Rogers, running for U.S. Senate in Michigan, faces backlash for misrepresenting his role in opioid legislation. Critics highlight his ties to Big Pharma and past policies that may have fueled the opioid crisis, raising concerns over his Senate bid.
Mike Rogers distorts opioid record to boost Senate bid

Controversy Surrounds Mike Rogers’ Claims on Opioid Legislation

Republican Senate candidate Mike Rogers, who is running for office in Michigan, has faced scrutiny over statements made in a recent editorial published by Deadline Detroit, where he claimed significant involvement in combating the opioid crisis during his congressional tenure.

Critics have pointed out that Rogers, during his congressional service from 2001 to 2015, was a proponent of the National Pain Care Policy Act. This legislation has been criticized for potentially encouraging the prescription of opioids like OxyContin to manage chronic pain, as detailed in a Bridge Michigan report.

Rogers asserted, “In Congress, I voted to allow Americans who are suffering from debilitating pain to have access to the treatment they need to live comfortably.” He further stated that the act included measures to mitigate overprescription and addiction issues.

However, these claims have been challenged. Critics argue that the act lacked any specific penalties for doctors who overprescribed opioids and did not impose any limits on prescriptions or enhance law enforcement capabilities concerning opioid distribution.

In 2003, Rogers publicly supported the National Pain Care Policy Act alongside the American Pain Society, which advocated for chronic pain treatment through pharmaceuticals. This organization disbanded in 2019 amid allegations of collaboration with pharmaceutical companies to promote opioid medications.

Rogers has also faced criticism over his financial ties to the pharmaceutical industry. Since 1999, he has reportedly received over $1 million in campaign contributions from pharmaceutical companies and other healthcare-related entities, raising concerns about potential conflicts of interest.

Data from the Michigan Department of Health and Human Services highlights a strong correlation between opioid prescription rates and overdose incidents in the state, notably between 2001 and 2010. A significant shift occurred in 2010 when the FDA implemented stricter regulations on opioid prescriptions and reformulated OxyContin to prevent misuse. Following these changes, there was a marked increase in heroin and fentanyl overdose cases.

With the Michigan Republican primary approaching on August 4, Rogers is seen as the frontrunner. He had previously run for the U.S. Senate in 2024 but was unsuccessful.

Several Democratic candidates, including Rep. Haley Stevens, state Sen. Mallory McMorrow, and physician Abdul El-Sayed, are also in the race, aiming to challenge Rogers in the upcoming election.


Read More Kitchen Table News

Share:

More Posts

Send Us A Message

Subscribe